Quote · Hard Fork
Hot I.P.O Summer + What Is A.I. Doing to Math? + HatGPT
Where this was said
The Third Wave of Philanthropy: How AI IPOs Could Reshape Giving
At 16:55 · chapter starts 14:00
Kevin Roose introduces a dimension of the AI IPO story that most outsiders miss: the sheer volume of philanthropic capital about to be unlocked. He references Nan Ransohoff's essay framing these IPOs as the 'third wave of philanthropy,' where tens or hundreds of billions could flood into charitable causes. The specific mechanics at Anthropic are striking: all eight co-founders pledged to give at least 80% of their personal wealth to charity, representing hundreds of billions of dollars at post-IPO valuations [1] — Kevin Roose "Anthropic co-founders pledged 80% to charity: All eight Anthropic co-founders pledged to give at least 80% of their wealth to charity, pote…" 16:01 . On top of that, Anthropic's employee stock-matching program offered early employees up to 3-to-1 matches for charitable pledges [2] — Kevin Roose "Anthropic employee stock matched 3-to-1: Anthropic matched early employees' charitable stock pledges at a 3-to-1 ratio, dramatically amplif…" 16:20 . Kevin Roose concludes that the combined effect could produce more philanthropic capital per year than the Gates Foundation — flowing primarily toward AI safety, global health, pandemic prevention, and effective altruism cause areas that the outside world might find 'fairly weird,' including, in Kevin's joking formulation, 'a great year to be a shrimp.'
All eight Anthropic co-founders pledged to give at least 80% of their wealth to charity, potentially earmarking hundreds of billions of dollars for philanthropy.
Anthropic matched early employees' charitable stock pledges at a 3-to-1 ratio, dramatically amplifying forthcoming philanthropic capital.
AI safety was the founding concern at both OpenAI and Anthropic, but going public adds a new force: the public markets will now pressure these companies to accelerate. Kevin Roose warns that when a truly dangerous model is ready, labs will face activist investors and stock market pressure on top of every other incentive to release it.